A phase II study of gemcitabine and TS-1 in erderly patients with advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Apr 2016 Status changed from recruiting to completed.
- 05 Mar 2009 New trial record.